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Microorganisms exist in the environment as multicellular communities that face the challenge of surviving under nutrient-
limited conditions. Chemical communication is an essential part of the way in which these populations coordinate 
their behavior, and there has been an explosion of understanding in recent years regarding how this is accomplished. 
Much less, however, is understood about the way these communities sustain their metabolism. Bacteria of the genus 
Pseudomonas are ubiquitous, and are distinguished by their production of colorful secondary metabolites called 
phenazines. In this article, we suggest that phenazines, which are produced under conditions of high cell density and 
nutrient limitation, may be important for the persistence of pseudomonads in the environment.
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Historically, microbiologists and chemists alike have categorized 
as ‘secondary metabolites’ a broad class of molecules produced at 
late stages of microbial growth in laboratory cultures. This nomen-
clature is, admittedly, pejorative, implying that these molecules are 
somehow less important than others to the cell that produces them. 
In particular, the traditional view is that secondary metabolites (i) 
do not contribute to the growth or survival of the producer (ii) are 
highly sensitive to the conditions stimulating their production (for 
example, medium composition) (iii) often have complex structures 
and (iv) have production rates that are decoupled from the doubling 
time of the cells1,2. Together, these leitmotifs present a conundrum: 
why would an organism limited for nutrients begin excreting large 
amounts of complex organic molecules? One reasonable and com-
monly stated answer is that they function as antibiotics, and are pro-
duced in copious quantities at this stage of growth to protect the 
producer from competitors3. In recent years, however, the idea that 
‘secondary’ metabolites might have other functions, ranging from 
controlling gene expression4 to supporting growth or iron acquisition 
in microbial communities5,6, has become increasingly compelling. 
This is due, in large part, to the recognition that microbes typically 
exist in nature in biofilm communities7 and/or in a metabolically 
quiescent state8; because the ‘rules of the game’ for metabolism under 
these conditions are virtually unknown, a re-examination of the func-
tion of secondary metabolites is warranted.
To illustrate the idea that secondary metabolites have the potential to 
perform primary metabolic functions, we will focus this review on a class 
of compounds known as ‘phenazines’, which have been of great inter-
est to pharmaceutical and clinical research groups for the last 50 years9. 
Phenazines are heterocyclic compounds that are produced naturally and 
substituted at different points around their rings by different bacte-
rial species (Table 1). Small modifications of the core phenazine 
structure give rise to a full spectrum of colors, ranging from the 
deep red of 5-methyl-7-amino-1-carboxyphenazinium betaine 
(aeruginosin A, 1) to the lemon yellow of phenazine-1-carboxylic 
acid (PCA, 2), to the bright blue of 1-hydroxy-5-methylphenazine 
(pyocyanin, 3) (Fig. 1). The combination and variety of functional 
groups added also determine the redox potential and solubility of 
these compounds, thus affecting their biological activity9–11.
The antagonistic effects of almost all of these derivatives are usually 
attributed to one general characteristic: redox activity. The 2-hydroxy-
phenazine-1-carboxylic acid (2-OHPCA, 4) produced by Pseudomonas 
aureofaciens is thought to kill off competing fungi through the pro-
duction of reactive oxygen species12. Many of the effects of pyocyanin 
(PYO) and PCA on a diversity of eukaryotic hosts as well as bacteria 
are thought to result from oxidative activity or the inactivation of 
proteins important in the oxidative stress response13,14. Regardless 
of whether they are acting as antibiotics in the soil, or virulence 
factors during infection, the redox transformations of phenazines 
strongly influence their physiological effects in other organisms. A 
more detailed understanding of phenazine metabolism in competing 
or host cells is emerging, as very recently, researchers have begun to 
recognize that small variations in the reactivity of phenazines can give 
rise to differences in their elicited response15.
Concomitant with the development of ideas about phenazine 
activity during competition and infection, Pseudomonas aeruginosa 
and other phenazine-excreting bacteria have become popular model 
organisms for the study of quorum sensing and biofilm formation, 
two of the most active areas of research in the field of microbiol-
ogy16–18. Whereas pharmaceutical and clinical groups have been 
focused on the physiological effects of these compounds in non-
producing organisms, microbial physiologists and geneticists have 
typically viewed phenazines as metabolites that perform only second-
ary functions. As a result, despite research interest in both the bio-
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logical activity of the compounds themselves and in the physiology 
of their producers, the primary functions of phenazines for produc-
ing organisms such as the pseudomonads are still unknown. This is 
surprising, especially given that phenazine production and reduction 
is evident in many of the Pseudomonas cultures that microbiologists 
prepare for their work (Fig. 2) and that the mechanisms thought 
to be responsible for phenazine metabolism in non-producers (for 
example, reduction by NADH or glutathione, interaction with the 
respiratory chain) are present in most organisms19,20. That phen-
azines and other excreted compounds (i) react with common pri-
mary metabolites (ii) are potentially transformed by enzymes active 
in central metabolic pathways and (iii) induce gene expression calls 
into question their categorization as secondary metabolites. We will 
discuss here the recent discoveries that lead to new hypotheses about 
the relevance of phenazine metabolism in the context of the lifestyles 
of their producers.
Occurrence of phenazine production
Phenazines are first mentioned in the literature as early as the 1860s, 
when French researchers and clinicians noticed a blue coloration in 
the pus and sputum, or respiratory secretion, of infected patients. 
Carle Gessard and others examined the pus microscopically and 
identified a rod-shaped bacterium residing in these wounds, and 
upon isolating the organism discovered that it was responsible for 
the bluish tint. For this trait, they named the species Bacillus pyo-
cyaneus, and it has since been renamed Pseudomonas aeruginosa, for 
the Latin aerugo, which refers to the blue-green rust of copper21. P. 
aeruginosa is widespread in terrestrial habitats, can grow in both 
marine and freshwater environments, and is known for its ability 
to infect a diversity of hosts, ranging from plants to humans21–23. 
The P. aeruginosa laboratory strains PAO1 and PA14 are capable of 
producing at least four different phenazine derivatives24.
Several other Pseudomonas species are also phenazine producers 
and are known for their potential in biocontrol applications, in which 
an organism that inhibits the growth of crop pathogens is enriched 
in the soil to enhance crop yields. Representatives include the strains 
P. aureofaciens 30-84, P. fluorescens 2-79 and P. chlororaphis PCL1391. 
Along with P. aeruginosa, these isolates all produce one or more phen-
azines and differ in their biosynthetic capabilities with respect to phen-
azine derivatization. 
P. aureofaciens, for 
example, possesses 
the mono-oxygenase 
PhzO, which converts 
the common pseu-
domonad phenazine 
precursor PCA into 
2-OHPCA, a bright 
orange pigment25. P. 
chlororaphis, on the 
other hand, expresses 
PhzH, a transamidase 
which converts this 
precursor into PCN, 
a green, sparingly 
soluble pigment that 
precipitates out of 
culture media26.
Phenazine biosyn-
thesis also has been 
observed in other 
bacterial genera, including other proteobacteria, such as Brevibacterium, 
Burkholderia and Xanthomonas, as well as the Gram-positive genus 
Streptomyces and even the archaeal genus Methanosarcina22,27,28. This 
review will focus on the pseudomonad phenazines, because they are 
the best studied with respect to biosynthesis, but will also include 
a discussion of the methanophenazine produced by Methanosarcina 
mazei Gö1, because it is the only phenazine thus far that has been 
unequivocally shown to have an important role in catabolism27.
Roles in eukaryotic physiology and pseudomonad persistence
Phenazines in infection. Some of the most thorough studies that have 
been conducted to investigate the physiological consequences of phen-
azine exposure are those of Britigan and colleagues, who have reported 
the many effects of phenazines produced by P. aeruginosa during infec-
tion of the human lung29. Phenazine production plays an important 
role in both acute and chronic P. aeruginosa lung infections, which are 
frequent causes of mortality in patients who have cystic fibrosis or oth-
erwise impaired lung function21. PYO has been detected in the sputum 
of patients with chronic P. aeruginosa infections at concentrations as 
high as 27 µg ml–1 (ref. 30), and the administration of purified PYO 
at comparable concentrations in laboratory mice has been shown to 
induce neutrophil influx in lung tissue31. Phenazine production is a 
common trait in strains of P. aeruginosa isolated from patients with 
cystic fibrosis32, and mutant versions of the P. aeruginosa strains PAO1 
and PA14 that are unable to synthesize PYO are attenuated in both acute 
and chronic mouse lung infection models33.
The oxidative activity of phenazines in particular has been shown 
to be important in pathogenesis during P. aeruginosa lung infection14. 
Both PYO and PCA can increase oxidant formation in human airway 
epithelial cells through a number of mechanisms including the oxidation 
of glutathione and NADH and inhibition of antioxidant enzymes13,15,34. 
Once it is reduced, PYO can then react with oxygen, forming superoxide 
radical and hydrogen peroxide35. Pyocyanin radical is also formed as 
an intermediate during its redox cycling, and can further contribute to 
the formation of reactive oxygen species36–39. These insults to the host 
cell’s internal redox balance may lead to increased secretion and thereby 
contribute to the generation of sputum, the physical and nutritional 
substrate for P. aeruginosa in the lungs of individuals with cystic fibro-
sis40,41. The generation of radical species (of phenazines and oxygen) 
Table 1  Characteristics of some phenazines excreted by pseudomonads90–92. Octanol-water partition coefficients (Kow) were 
calculated using the KOWWIN demo program available at http://www.syrres.com/esc/est_kowdemo.htm. E°′, standard redox 







No Name R1 R2 R3 R4 KOW ox KOW red EO′ (mV)
1 Aeruginosin A COOH CH3 NH2 –0.71 0.46 NA
2 Phenazine-1-carboxylic acid (PCA) COOH 2.17 3.72 –177
3 Pyocyanin (PYO) OH CH3 1.60 2.89 –34
4 2-Hydroxyphenazine-1-carboxylic acid 
(2-OHPCA)
COOH OH 2.54 3.32 NA
5 Phenazine-1-carboxamide (PCN) CONH2 1.04 2.19 –115
6 1-Hydroxyphenazine (1-OHPHZ) OH 1.81 2.35 –172
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In Pseudomonas spp., the phenazine bio-
synthetic pathway branches off from the shi-
kimic acid pathway, which is also the source 
for metabolites such as the aromatic amino 
acids, siderophores and quinones (Scheme 
1)45–47. Genes encoding the phenazine bio-
synthetic enzymes are arranged in one core 
operon, phzABCDEFG, in most phenazine-
producing pseudomonads25,48. Such an 
operon exists in the genome of P. aeruginosa 
in duplicate, and the expression of the two 
copies of the operon is differentially regu-
lated24. In many strains, additional genes 
involved in phenazine decoration, such as 
phzM, phzS, phzO and phzH, are present in 
single copy and can be located proximally to 
the core operon or elsewhere in the genome26; 
currently, little is known about how these genes are regulated.
Expression of phenazine biosynthetic genes is regulated by multiple 
mechanisms, which are strongly influenced by environmental condi-
tions. One of the primary factors governing phenazine production is 
population density, and in P. aeruginosa this dependency is effected by 
at least three quorum-sensing systems49,50. Bacteria participating in quo-
rum sensing release intercellular signals such as N-acyl-L-homoserine 
lactones (AHLs, 7 and 8) and 2-heptyl-3-hydroxy-R-quinolone (the 
Pseudomonas quinolone signal, PQS, 9) into the environment, where 
they can be taken up by neighboring cells of the same or different spe-
cies (Fig. 3). Inside the cell, these compounds induce the expression of 
genes for their own biosynthesis—as well as many other genes important 
in virulence, competition and behavior—when they accumulate to a 
threshold concentration18. The dependence of phenazine biosynthesis 
on cell density has also been demonstrated for biocontrol pseudomo-
nads, and in these species is mediated by a seemingly less complex quo-
rum-sensing network51–53.
In addition to cell density, numerous environmental factors have been 
identified that affect the regulation of phenazine biosynthesis, including 
is potentially harmful to other microbes competing for resources in 
the lung, such as Staphylococcus aureus, and may help P. aeruginosa to 
persist in this environment42. However, recent work has demonstrated 
that phenazine production is beneficial to the growth or survival of P. 
aeruginosa in mouse infection models even in the absence of competing 
organisms, implying that these compounds may additionally provide a 
physiological benefit to their producers during infection33.
Phenazines in soil ecosystems. The other well-studied niche for 
phenazine-producing pseudomonads is the rhizosphere, the zone sur-
rounding the roots of plants. As is the case for P. aeruginosa in an infected 
lung, species such as P. aureofaciens, P. fluorescens and P. chlororaphis 
compete in this ecosystem with other organisms for resources. More 
importantly, they compete for colonization sites on the roots of agricul-
turally important crops, where they thrive as microcolonies (biofilms) 
and protect the plants from pathogenic fungi. Phenazines are thought to 
be important in this competition, and consistent with this, phenazine-
producing strains of P. aureofaciens and P. fluorescens are better able to 
colonize the roots of wheat plants and persist in the rhizosphere than 
are phenazine-lacking mutants43.
The toxicity of phenazines to bacteria and fungi typically present in the 
rhizosphere has been demonstrated, and again is thought to be mostly 
due to the generation of reactive oxygen species12. If biocontrol strains 
did use phenazine toxicity as a weapon to compete with indigenous soil 
populations for resources, one would expect the composition of rhizo-
sphere communities to change after exposure to phenazines; however, 
this does not occur. The overall number of organisms competing with P. 
fluorescens for resources does not decline after this strain has colonized 
the root44. This implies that it is not just the antibiotic activity of phen-
azines that is important for the ability of their producers to compete in 
the soil. As is the case for phenazines produced by P. aeruginosa, there is 
evidence indicating that phenazines have roles in the physiology and thus 
the ecological competence of the biocontrol pseudomonads.
Biosynthesis of phenazine derivatives
As mentioned above, the early observation that phenazines are pro-
duced in stationary phase in typical lab cultures led to the general view 
that they were unimportant in metabolism. However, we now know 
that phenazines are produced in biofilms and as a result are present in 
detectable quantities in the rhizosphere and in the lungs of cystic fibrosis 
patients. This has fueled interest in the phenazine biosynthetic pathway 
and the environmental factors that influence expression of the biosyn-
thetic genes. The complexity of the regulation of phenazine biosynthesis 
is only just beginning to be appreciated and is consistent with the high 
degree of biological activity shown by these compounds.
Figure 1  Phenazines are colorful, diffusible bacterial metabolites. (a) Streak plate of the biocontrol 
strain P. aureofaciens 30-84. The phenazine 2-OHPCA turns the agar bright orange. (b) Aqueous 
solutions of some of the phenazines produced by various Pseudomonas strains.
 2-OHPCA            PCA             1-OHPHZ             PYO
a b
Figure 2  Pseudomonads stimulate phenazine reduction. (a) Characteristic 
gradient formed by standing cultures of P. aeruginosa. Bacterial respiration 
renders most of the culture anoxic. Phenazines (phz) are reduced and, in 
the case of PYO, become colorless. The darker blue at the top represents 
oxidized PYO. (b) Half-reaction representing generic two-electron phenazine 
reduction. (c) Schematic of phenazine reduction and auto-oxidation 
responsible for gradient formation in standing cultures. Reduced phenazines 
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oxygen, iron and phosphate concentration as well as the nature of the 
carbon sources available54. For many of these effects, it is not entirely 
clear whether they are above quorum sensing in the regulatory cascade 
(for example, iron limitation induces quorum-signal production, which 
in turn induces phenazine biosynthesis) or are the result of regulators 
acting independently of quorum sensing55. The GacA/S two-compo-
nent system, which effects global changes in transcription, has been 
implicated in the control of phenazine biosynthesis and is thought to act 
by regulating quorum sensing, but there is also evidence that it affects 
phenazine gene expression through other mechanisms56–58. Repressors 
of phenazine biosynthesis have been identified in the plant symbionts P. 
aureofaciens and P. chlororaphis. Mutations in these repressors seem to 
override the quorum-sensing regulation of phenazine biosynthesis in 
these organisms, resulting in constitutive phenazine production58,59.
Intercellular signaling: a regulatory role for phenazines
Recent work from our laboratory has contributed to understanding of 
the complexity of the P. aeruginosa quorum-sensing system and the place 
of phenazines in this cell density-dependent cascade. We have found 
that, in addition to being regulated by cell-cell communication, phen-
azines themselves can act as intercellular signals. Our work indicates that 
PYO is the physiological inducer of a set of genes previously identified 
as members of the quorum-sensing regulon. PYO acts downstream of 
PQS, which previously had been deemed the terminal signal in the P. 
aeruginosa quorum-sensing cascade. PYO’s function as a quorum signal 
explains what was thought to be a delayed response in the expression 
of a specific set of genes in response to PQS49. We now understand 
that these genes are expressed later than those induced directly by PQS 
because PQS first has to upregulate the biosynthesis of phenazines so 
that PYO can subsequently induce its stimulon (ref. 60 and unpublished 
data) (Fig. 3).
The signaling function of PYO makes it the newest addition to the 
growing list of small molecules excreted by P. aeruginosa that have been 
shown to perform multiple functions61. PQS, like PYO, was also long 
recognized for its antibiotic and virulence properties before its role 
in signaling was elucidated62. Recent studies have demonstrated that 
certain AHL and quinolone derivatives chelate iron63,64, raising the 
possibility that these metabolites facilitate iron uptake in vivo. The accu-
mulating knowledge about the chemistry and 
biological activity of small molecules excreted 
by Pseudomonas spp. calls for a re-evaluation 
of our categorizations of these compounds. 
Rather than clearly performing one dedicated 
purpose, they seem to be capable of multiple 
roles. To determine the most important physio-
logical effects of phenazines and other small 
metabolites in the environment and dur-
ing infection, we will need to understand the 
physiological conditions allowing, requiring 
and regulating their activities. Elucidating their 
mechanisms of action at the molecular level 
may also provide indications of the conditions 
relevant for activity.
Other physiological roles
In addition to inducing gene expression, phen-
azines also act as substrates in intracellular 
redox transformations. This further metabolism 
of phenazines, subsequent to their biosynthesis, 
can be observed as a color change in pseudo-
monad cultures that have become limited for 
terminal electron acceptors. This is because pseudomonads reduce their 
own phenazines, and changing the oxidation state of a phenazine changes 
its absorbance spectrum. In cultures of the bacterium P. aeruginosa, this 
is observed as a loss of blue coloration, because the main phenazine pro-
duced by this organism, PYO, changes from blue to colorless upon reduc-
tion at neutral pH (Fig. 2)65. This activity has also been demonstrated in 
oxygen-limited cultures of the bacterium P. chlororaphis, which can use 
its phenazine product, phenazine-1-carboxamide (PCN, 5) to reduce 
extracellular iron oxides5. Although a good deal of research effort has 
gone toward understanding phenazine reduction by mammalian cells, 
less work has been done to elucidate the mechanisms of the phenazine 
reduction that is readily observed in pseudomonad cultures. Here, we will 
discuss what is known about phenazine reduction and its physiological 
functions in phenazine-producing and non-producing prokaryotes.
Phenazines as ‘respiratory pigments.’ Based on the redox potentials, 
metabolism and solubilities of phenazines, it has been proposed that 
phenazines act as electron acceptors in cellular energy generation or in 
the maintenance of the intracellular redox balance66. Studies conducted 
by Ernst Friedheim in the 1930s, in which he observed that PYO increased 
the oxygen consumption of cell suspensions of P. aeruginosa67, support 
this idea. Several reports on the interactions of PYO and 1-hydroxyphen-
azine (1-OHPHZ, 6) with the mammalian respiratory chain were pub-
lished in the decades that followed. 1-OHPHZ, but not PYO, was shown 
to inhibit respiration at the level of ubiquinone in the electron transport 
chain of mammalian cells. It was concluded, based on measurements of 
oxygen depletion (which did not decrease in the presence of PYO) that 
PYO did not inhibit mammalian cell respiration19,68. We question this 
interpretation, however, given that PYO can accept electrons from NADH 
and transfer them to oxygen; accordingly, what was thought to be normal 
respiration may actually have been short-circuiting of the electron trans-
port chain by PYO. In contrast, it makes sense that oxygen depletion was 
not observed in the presence of 1-OHPHZ given that reduced 1-OHPHZ 
does not react with oxygen at appreciable rates69.
Notably, the interactions of phenazines with the pseudomonad respi-
ratory chain are largely unknown. Numerous groups have observed that 
both synthetic and natural phenazines are reduced by prokaryotes, but 
in most cases the physiological effect of this reduction has not been 
































Scheme 1  Phenazine biosynthesis and its relation to the shikimic acid pathway in 
pseudomonads24,45,46,93.
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respiratory chain of M. mazei Gö1 (ref. 72). This archaeon produces 
methanophenazine, a phenazine derivative with a pentaisoprenoid side 
chain, and can utilize phenazines in lieu of quinones in electron trans-
port. In vitro, methanophenazine has been shown to accept electrons 
from hydrogen or a reduced coenzyme by means of the activity of either 
of two membrane-bound dehydrogenases, one of which is homolo-
gous to the NADH dehydrogenase found in bacteria and mitochon-
dria. Reduced methanophenazine can then donate electrons to another 
cofactor in a reaction catalyzed by a membrane-bound heterodisulfide 
reductase73. In vivo, these respiratory enzymes couple electron transport 
to the translocation of protons, generating a proton gradient that can 
be used to make ATP74. In M. mazei, therefore, phenazine reduction is 
not only crucial to energy metabolism in that it reoxidizes the NADH 
analog found in methanogens, but it is presumably also required for 
ATP synthesis72,75. Whether phenazine reduction can be similarly used 
by phenazine-producing pseudomonads to reoxidize NADH or generate 
ATP is still an open question.
Phenazines in  redox homeostasis and iron acquisition  Advances 
in our understanding of bacterial communities have  provided an 
environmental context for the hypothesis that pseudomonads  benefit 
by reducing phenazines. It has been proposed that the reduction of 
diffusible small molecules is advantageous during growth in a biofilm, 
a surface-attached population of bacteria suspended in an excreted 
matrix66. The diffusion rate of oxygen through a biofilm is thought to 
be slow, and cells at the base of an aerobic biofilm become limited for 
oxidants76,77. Under this condition, phenazines could allow bacteria 
to generate energy for growth or help maintain redox homeostasis by 
 acting as electron acceptors for the reoxidation of accumulating NADH. 
Indeed, maintaining a proper redox balance in the pyridine nucleotide 
pool is essential for metabolism78, and recent work from our lab indicates 
that P. aeruginosa phenazine-negative mutants have higher intracellular 
NADH/NAD+ ratios in stationary phase than does the parent strain in 
planktonic cultures(unpublished data). This suggests that an important 
role for phenazines could be to serve as intracellular redox ‘buffers’.
Various research groups have recently become more interested 
in phenazine reduction by biofilm-forming bacteria because phen-
azines make excellent electron transfer mediators to electrodes in 
 biological fuel cells79. In biological fuel cells deployed in the envi-
ronment as well as those set up in laboratories, bacteria often grow 
as biofilms attached to the electrode surface80,81. That phenazines 
facilitate electron  transfer to electrodes has been demonstrated by 
Zeikus and colleagues, who investigated the ability of Escherichia 
coli to reduce the synthetic  phenazine neutral red. They showed that 
E. coli is able to use this synthetic  phenazine as an electron transfer 
mediator in the  reduction of iron oxide, and presented evidence 
indicates that  hydrogenase is at least partially responsible for this 
Figure 3  Model of the quorum-sensing network in Pseudomonas aeruginosa. The quorum-sensing network in Pseudomonas aeruginosa comprises a cascade of 
three types of signaling molecules that function in a growth stage–dependent manner. The AHLs 3-oxo-C12-HSL and C4-HSL are released in exponential phase 
and control the production of the quinolone PQS. PQS accumulates in late exponential phase and is required for the synthesis of phenazines. Recent findings 
from our laboratory show that the phenazine PYO upregulates genes that have previously been demonstrated to be controlled by quorum sensing, establishing 
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Figure 4  Key structural elements of secondary metabolites resemble those 
of cofactors that have critical roles in energy metabolism. (a) Pyocyanin. 
(b) Generic flavin. (c) Prodigiosin, an antibiotic produced by Serratia 
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capability71. Our group as well as others have shown that other 
synthetic dyes, with structures resembling those of  phenazines, are 
reduced by Bacillus, Lactococcus and Shewanella  species5,70,82. The 
Verstraete group has shown that phenazine  production enhances 
power output from microbial fuel cells, and that biofuel cells enrich 
for phenazine-producing organisms; whether  phenazine  production 
 influences the growth or survival of these bacteria in this context 
remains unclear83,84.
Aside from these proposed roles in energy generation, it has been 
suggested that phenazine reduction could act to make iron more 
available to the producing organism. PYO may assist infectious P. 
aeruginosa in the acquisition of iron by reducing it and freeing it from 
transferrin, a protein that normally sequesters iron so that it is avail-
able only to the human host85. As mentioned above, P. chlororaphis 
has been shown to reduce iron oxides through electron transfer to 
PCN, and it is thought that this ability may be important in the rhi-
zosphere, where iron is present predominantly in an insoluble form5. 
An examination of the relationship between iron availability and the 
regulation of phenazine biosynthesis, however, presents a complicated 
picture that neither refutes nor supports a role for these compounds 
in iron acquisition. Although in many cases it has been reported that 
phenazine production is enhanced in iron-deprived cultures, other 
studies have demonstrated a requirement for iron in media optimized 
for phenazine biosynthesis54,85,86. These differences probably arise 
from the high degree of variability with respect to other parameters, 
such as carbon source and the concentrations of oxygen and various 
salts. Perhaps the best way to ascertain whether or not iron avail-
ability has relevance to phenazine production will be to observe its 
effects under conditions that imitate the most common habitats for 
phenazine-producing pseudomonads41.
How are phenazines reduced?  Although we are beginning to 
recognize the potential physiological importance of phenazine 
redox cycling, we have yet to identify the mechanisms by which 
pseudomonads catalyze the reduction of these compounds. On 
the basis of their low redox potentials and the mechanisms for 
phenazine reduction identified in eukaryotic cells, we might predict 
that NADH or glutathione would act as electron donors in these 
reactions. In the case of PYO, an enzyme may not be required, given 
that this compound reacts with these electron donors spontaneously. 
However, the relatively rapid reduction of other phenazines by 
bacterial suspensions is thought to require one or more enzymes71 . 
The flavin-like structures of phenazines lead us to hypothesize that 
flavin-cofactored enzymes, capable of accepting electrons from low-
potential donors such as NADH, might be responsible for catalyzing 
these transformations. If such an enzyme were associated with 
the respiratory chain, pseudomonads might be able to couple the 
reduction of their own excreted metabolites to the generation of a 
proton-motive force; in the absence of a better electron acceptor, 
they could utilize phenazines to generate ATP. Alternatively, if the 
enzyme were not associated with respiration, or were not a coupling 
site for proton transfer, phenazine reduction could still serve the 
valuable function of reoxidizing NADH under conditions in which 
the intracellular NADH/NAD+ pool had shifted toward reducing.
Conclusions
As more is learned about the chemistry and biological activity of phen-
azines, we begin to question their categorization as ‘secondary’ metabo-
lites. This compels us to rethink secondary metabolism as a phenomenon 
more generally. It is striking that the conditions under which secondary 
metabolites are produced in laboratory cultures (that is, stationary phase) 
are effectively the same as those that define many microbial habitats in 
nature8. Consistent with this, gene expression and physiological attri-
butes seem to be very similar in stationary-phase planktonic cultures 
and biofilms87,88. As we have discussed for phenazines, stationary-phase 
metabolites can allow bacteria to sense the conditions of their surround-
ings and induce appropriate changes in gene expression; moreover, they 
can facilitate extracellular electron transfer to oxidants such as insol-
uble iron5,24 and have the potential to play a role in redox homeosta-
sis. Notably, phenazines are only one class among the myriad natural 
products made by microorganisms89, many of which bear intriguing 
structural resemblances to cofactors that have important roles in primary 
metabolism (Fig. 4). Now that we are beginning to understand station-
ary-phase physiology and its ecological relevance, it is time to revisit the 
roles of these compounds in gene expression and survival. We suspect 
that such studies will further blur the line between primary and second-
ary metabolism and will lead to a more complete picture of the mecha-
nisms allowing organisms to persist in dynamic environments.
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